1、State of InsurtechGlobal|Q3 2024Global data and analysis on dealmaking,funding,and exits by private market insurtech companiesState of Insurtech2 2Make smartertech decisions.Our platform will help you discover,understand,and manage your response to emerging tech.Make confident tech decisions that dr

2、ive growth,improve operations,and beat the competition with CB Insights.IIIITry our platform free!Sign up for a free trialState of Insurtech3 3“Steal”our data.Download the underlying data in this report.If you create any analysis or visualizations with this data,send it our way and you could be feat

3、ured in the CBI newsletter.us on social LinkedIn X(Twitter)InstagramIIIIDownload the raw dataSign up for a free trialTLDR$1.4BQuarterly insurtechfunding sees no change from Q224.Insurtech funding remained flat quarter-over-quarter(QoQ)at$1.4B.$0.7B was raised across both L&H and P&C insurtech in Q32

4、4,one of just 3 quarters since 2020 where L&H insurtechs have rivaled P&C for quarterlyfunding.See the data 477Insurtech deals.Fewest in a quarter since 2016.Insurtech deal count fell 42%year-over-year,from 132 in Q323 to 77 in Q324.Q216 was the last quarter to see fewer insurtech deals(60).Even so,

5、Q324 saw the first insurtech unicorn birth in a year Altana AI raised at a$1B valuation.See the data 55%Percent of funding to$100M+mega-round deals.Q324 saw$0.8B in mega-round funding across 5 deals,both 2-year highs.Altana AI,which offers a supply chain risk platform,raised the quarters largest dea

6、l($200M Series C).Devoted Health and Zing Health,which offer Medicare Advantage plans,raised 2 of the other mega-round deals.See the data$4MRecord-high early-stage deal size in 2024 YTD.Median early-stage insurtech deal size has grown from$2.5M in 2023 to$4M in 2024 so far.Comparatively,median early